These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
368 related items for PubMed ID: 7719248
21. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium. Birkmann J, Oez S, Smetak M, Kaiser G, Kappauf H, Gallmeier WM. Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219 [Abstract] [Full Text] [Related]
22. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression. Arcasoy MO, Maun NA, Perez L, Forget BG, Berliner N. Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594 [Abstract] [Full Text] [Related]
23. Growth factor receptor expression during in vitro differentiation of partially purified populations containing murine stem cells. Ashihara E, Vannucchi AM, Migliaccio G, Migliaccio AR. J Cell Physiol; 1997 Jun; 171(3):343-56. PubMed ID: 9180904 [Abstract] [Full Text] [Related]
24. Ultrastructural and phenotypic analysis of in vitro erythropoiesis from human cord blood CD34+ cells. Kie JH, Jung YJ, Woo SY, Ryu KH, Park HY, Chung WS, Seoh JY. Ann Hematol; 2003 May; 82(5):278-83. PubMed ID: 12679887 [Abstract] [Full Text] [Related]
25. Erythropoietin-dependent induction of hemoglobin synthesis in a cytokine-dependent cell line M-TAT. Minegishi N, Minegishi M, Tsuchiya S, Fujie H, Nagai T, Hayashi N, Yamamoto M, Konno T. J Biol Chem; 1994 Nov 04; 269(44):27700-4. PubMed ID: 7961690 [Abstract] [Full Text] [Related]
26. Murine erythroid cell lines derived with c-myc retroviruses respond to leukemia-inhibitory factor, erythropoietin, and interleukin 3. Cory S, Maekawa T, McNeall J, Metcalf D. Cell Growth Differ; 1991 Mar 04; 2(3):165-72. PubMed ID: 1905566 [Abstract] [Full Text] [Related]
27. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro. Tanimukai S, Kimura T, Sakabe H, Ohmizono Y, Kato T, Miyazaki H, Yamagishi H, Sonoda Y. Exp Hematol; 1997 Sep 04; 25(10):1025-33. PubMed ID: 9293899 [Abstract] [Full Text] [Related]
28. A novel CD10-positive erythroid cell line, RM10, established from a patient with chronic myelogenous leukemia. Hirata J, Sato H, Takahira H, Shiokawa S, Endo T, Nishimura J, Katsuno M, Masuda S, Sasaki R, Fukumaki Y. Leukemia; 1990 May 04; 4(5):365-72. PubMed ID: 2167410 [Abstract] [Full Text] [Related]
29. SCL is coexpressed with GATA-1 in hemopoietic cells but is also expressed in developing brain. Green AR, Lints T, Visvader J, Harvey R, Begley CG. Oncogene; 1992 Apr 04; 7(4):653-60. PubMed ID: 1565464 [Abstract] [Full Text] [Related]
30. In vivo erythroid recovery following paclitaxel injury: correlation between GATA-1, c-MYB, NF-E2, Epo receptor expressions, and apoptosis. Romero-Benitez MM, Aguirre MV, Juaristi JA, Alvarez MA, Trifaró JM, Brandan NC. Toxicol Appl Pharmacol; 2004 Feb 01; 194(3):230-8. PubMed ID: 14761679 [Abstract] [Full Text] [Related]
31. Transcriptional and posttranscriptional regulation of erythroid gene expression in anthracycline-induced differentiation of human erythroleukemic cells. Morceau F, Chénais B, Gillet R, Jardillier JC, Jeannesson P, Trentesaux C. Cell Growth Differ; 1996 Aug 01; 7(8):1023-9. PubMed ID: 8853898 [Abstract] [Full Text] [Related]
32. Erythroid-specific activation of the distal (testis) promoter of GATA1 during differentiation of purified normal murine hematopoietic stem cells. Migliaccio AR, Migliaccio G, Ashihara E, Moroni E, Giglioni B, Ottolenghi S. Acta Haematol; 1996 Aug 01; 95(3-4):229-35. PubMed ID: 8677748 [Abstract] [Full Text] [Related]
33. Involvement of H-ras in erythroid differentiation of TF1 and human umbilical cord blood CD34 cells. Ge Y, Li ZH, Marshall MS, Broxmeyer HE, Lu L. Blood Cells Mol Dis; 1998 Jun 01; 24(2):124-36; discussion 137. PubMed ID: 9628849 [Abstract] [Full Text] [Related]
34. Erythropoietin-dependent suppression of the expression of the beta subunits of the interleukin-3 receptor during erythroid differentiation. Carta C, Campisi S, Migliaccio G, Migliaccio AR. Blood Cells Mol Dis; 2000 Oct 01; 26(5):467-78. PubMed ID: 11112384 [Abstract] [Full Text] [Related]
35. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181). Estrov Z, Talpaz M, Zipf TF, Kantarjian HM, Ku S, Ouspenskaia MV, Hirsch-Ginsberg C, Huh Y, Yee G, Kurzrock R. J Cell Physiol; 1996 Mar 01; 166(3):618-30. PubMed ID: 8600166 [Abstract] [Full Text] [Related]
36. Granulocyte-macrophage colony-stimulating factor-dependent growth and erythropoietin-induced differentiation of a human cell line MB-02. Morgan DA, Gumucio DL, Brodsky I. Blood; 1991 Dec 01; 78(11):2860-71. PubMed ID: 1954374 [Abstract] [Full Text] [Related]
37. Regulation of both erythroid and megakaryocytic differentiation of a human leukemia cell line, UT-7. Miura Y, Kirito K, Komatsu N. Acta Haematol; 1998 Dec 01; 99(3):180-4. PubMed ID: 9587401 [Abstract] [Full Text] [Related]
38. Establishment and characterization of a novel human immature megakaryoblastic leukemia cell line, M-MOK, dependent on fibroblasts for its viability. Itano M, Tsuchiya S, Minegishi N, Fujie H, Minegishi M, Morita S, Yambe T, Ohashi Y, Masuda T, Koike T. Exp Hematol; 1995 Nov 01; 23(12):1301-9. PubMed ID: 7589286 [Abstract] [Full Text] [Related]
39. Expression of GATA-1 mRNA in human myeloid leukemic cells. Guerrasio A, Saglio G, Rosso C, Alfarano A, Camaschella C, Lo Coco F, Biondi A, Rambaldi A, Nicolis S, Ottolenghi S. Leukemia; 1994 Jun 01; 8(6):1034-8. PubMed ID: 8207977 [Abstract] [Full Text] [Related]
40. Erythroid progenitors differentiate and mature in response to endogenous erythropoietin. Sato T, Maekawa T, Watanabe S, Tsuji K, Nakahata T. J Clin Invest; 2000 Jul 01; 106(2):263-70. PubMed ID: 10903342 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]